Related Experiment Video

Updated: Jul 2, 2026

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
07:25

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

Published on: March 6, 2018

Treatment of prostate cancer: therapeutic potential of targeted immunotherapy with APC8015

Robert A Bok1

  • 1Department of Radiology, University of California at San Francisco San Francisco, CA, USA.

Therapeutics and Clinical Risk Management
|August 30, 2008
PubMed

Insights

The immune system can fight prostate cancer, but tumors often resist. Sipuleucel-T (APC8015) boosts the anti-tumor response, slowing disease progression and improving survival in advanced cases.

Area of Science:

  • Immunology
  • Oncology
  • Cancer Therapeutics

Background:

  • The immune system possesses inherent capabilities to identify and combat prostate cancer cells.
  • Tumor cell-intrinsic properties frequently impede the immune system's anti-cancer efficacy.
  • Immunotherapy presents a promising strategy to augment the body's natural defenses against cancer.

Purpose of the Study:

  • To evaluate the efficacy of APC8015 (Sipuleucel-T) in enhancing anti-tumor immune responses.
  • To assess the impact of APC8015 on disease progression and survival in advanced prostate cancer patients.

Main Methods:

  • APC8015 involves the ex vivo stimulation of a patient's own antigen-presenting cells (APCs).
  • Late-phase clinical trials were conducted to gather efficacy and safety data.
  • The study focused on patients with advanced prostate cancer.

Main Results:

  • APC8015 demonstrated evidence of slowing disease progression in patients with advanced prostate cancer.
  • Treatment with APC8015 was associated with increased survival rates.
  • The immunotherapeutic approach showed a positive impact on patient outcomes.

Conclusions:

  • APC8015 (Sipuleucel-T) represents a viable immunotherapeutic option for advanced prostate cancer.
  • This approach holds significant promise for improving treatment strategies against prostate cancer.
  • Further development of such immunotherapies could offer valuable new tools in oncology.
Keywords:
antigen presenting cellsimmunologicsprostate cancer

More Related Videos

A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance05:19

A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance

Published on: November 7, 2025

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...